{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:49:02Z","timestamp":1789940942438,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Port catheters are indispensable in modern oncologic and medical care. Despite their benefits, complications such as skin erosion and related mechanical issues remain a significant concern. While numerous studies have explored prevention and management strategies, the influence of port reservoir thickness on these complications has not been systematically evaluated. This study investigates whether port thickness independently contributes to skin erosion risk, aiming to inform device selection and placement strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included 662 patients who underwent port catheter implantation at Istanbul Ba\u015fak\u015fehir \u00c7am ve Sakura City Hospital between June 2022 and October 2024. Data on demographics, port brand, reservoir height, and revision status were analyzed. Appropriate nonparametric tests were used for group comparisons, and Spearman correlation and multivariate logistic regression were performed to assess the association between reservoir height and revision risk. A p-value\u2009&lt;\u20090.05 was considered statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 662 patients, 29 experienced skin erosion requiring revision, corresponding to a 4.4% overall revision rate. All revisions were due to skin erosion; no major or infectious complications occurred. Reservoir heights of the four port brands, 10.6\u00a0mm (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009257), 11.6\u00a0mm (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200958), 12.2\u00a0mm (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009219), and 13.2\u00a0mm (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009128), demonstrated a trend toward higher revision rates with increasing port thickness. Spearman correlation analysis demonstrated a weak but significant positive relationship between reservoir height and revision risk (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.168,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), indicating a size-dependent trend. In multivariate logistic regression, both port reservoir height and anti-VEGF therapy emerged as independent predictors of revision. Compared with 10.6-mm ports, 12.2-mm and 13.2-mm ports were associated with 4.47- and 10.39-fold higher revision risks (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). Anti-VEGF therapy increased the revision risk by approximately 2.9-fold (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Port reservoir thickness is an independent predictor of skin erosion requiring revision. Thicker ports were linked to higher complication rates, particularly in patients receiving anti-VEGF therapy, underscoring the importance of device selection and design considerations in clinical practice. These findings suggest that thinner-profile ports should be preferred when feasible. Prospective studies are needed to validate these findings and establish evidence-based recommendations for port selection and placement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13019-025-03817-9","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:03:22Z","timestamp":1767189802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Port catheter thickness and its correlation with complications - exploring the millimeter threshold"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-2772","authenticated-orcid":false,"given":"Omer","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-5851","authenticated-orcid":false,"given":"Mehlika","family":"Iscan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"3817_CR1","unstructured":"Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi veE. Totally implanted venous and arterial access system to replace external catheters in cancer treatment, Surgery, c. 92, sy 4, ss. 706\u2013712, Eki. 1982."},{"issue":"4","key":"3817_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0011-3840(96)80008-6","volume":"33","author":"ED Whitman","year":"1996","unstructured":"Whitman ED. Complications associated with the use of central venous access devices. Curr Probl Surg. 1996;33(4):309\u201378. https:\/\/doi.org\/10.1016\/S0011-3840(96)80008-6.","journal-title":"Curr Probl Surg"},{"issue":"6","key":"3817_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.6.700","volume":"286","author":"J Merrer","year":"2001","unstructured":"Merrer J. Complications of femoral and subclavian venous catheterization in critically ill patientsA randomized controlled trial. JAMA. 2001;286(6):700. https:\/\/doi.org\/10.1001\/jama.286.6.700.","journal-title":"JAMA"},{"key":"3817_CR4","doi-asserted-by":"publisher","DOI":"10.2147\/MDER.S67756","author":"G Guiffant","year":"2014","unstructured":"Guiffant G, Flaud P, Durussel J-J, Merckx J. Impact of the shape of the implantable ports on their efficiency of flow (injection and flushing). Med Devices Evid Res. 2014. https:\/\/doi.org\/10.2147\/MDER.S67756.","journal-title":"Med Devices Evid Res"},{"key":"3817_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211059949","volume":"9","author":"D Panetta","year":"2021","unstructured":"Panetta D, Tollapi L, Paolicchi A, Marri E, Aringhieri G, Caramella D. Comparative structural analysis of polyurethane and silicone catheters of totally implantable venous access devices by micro-computed tomography. SAGE Open Med. 2021;9:20503121211059949. https:\/\/doi.org\/10.1177\/20503121211059949.","journal-title":"SAGE Open Med"},{"key":"3817_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/MDER.S125605","volume":"Volume 10","author":"G Guiffant","year":"2017","unstructured":"Guiffant G, Flaud P, Royon L, Burnet E, Merckx J. Mechanical characteristics of plastic base Ports and impact on flushing efficacy. Med Devices Evid Res. 2017;Volume 10:11\u20135. https:\/\/doi.org\/10.2147\/MDER.S125605.","journal-title":"Med Devices Evid Res"},{"key":"3817_CR7","doi-asserted-by":"publisher","unstructured":"Shigyo vd H. Safety of early bevacizumab administration after central venous Port placement for patients with colorectal cancer. Cancers C. 2023;15. https:\/\/doi.org\/10.3390\/cancers15082264. sy 8, s. 2264, Nis.","DOI":"10.3390\/cancers15082264"},{"key":"3817_CR8","doi-asserted-by":"publisher","unstructured":"Kriegel vd I. Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy, Anticancer. Drugs, c. 22, sy 10, ss. 1020\u20131023, Kas. 2011, https:\/\/doi.org\/10.1097\/CAD.0b013e328349c7bb","DOI":"10.1097\/CAD.0b013e328349c7bb"},{"issue":"6","key":"3817_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/SAP.0b013e3181828141","volume":"62","author":"CR Gordon","year":"2009","unstructured":"Gordon CR. A review on Bevacizumab and surgical wound healing: an important warning to all surgeons. Ann Plast Surg. 2009;62(6):707\u20139. https:\/\/doi.org\/10.1097\/SAP.0b013e3181828141.","journal-title":"Ann Plast Surg"},{"key":"3817_CR10","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7185","author":"D Kim","year":"2019","unstructured":"Kim D, Ryu D, Jung H, Lee veS. Evaluation of complications of totally implantable central venous Port system insertion. Exp Ther Med Oca. 2019. https:\/\/doi.org\/10.3892\/etm.2019.7185.","journal-title":"Exp Ther Med Oca"},{"issue":"3","key":"3817_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1188\/04.CJON.309-310","volume":"8","author":"JM Brant","year":"2004","unstructured":"Brant JM, Camp-Sorrell D. Implanted ports: skin erosion. Clin J Oncol Nurs. 2004;8(3):309\u201310. https:\/\/doi.org\/10.1188\/04.CJON.309-310.","journal-title":"Clin J Oncol Nurs"},{"issue":"7","key":"3817_CR12","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1007\/s00520-020-05871-6","volume":"29","author":"LV Tumay","year":"2021","unstructured":"Tumay LV, Guner OS. Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study. Support Care Cancer. 2021;29(7):3531\u20138. https:\/\/doi.org\/10.1007\/s00520-020-05871-6.","journal-title":"Support Care Cancer"},{"issue":"4","key":"3817_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1188\/14.CJON.403-405","volume":"18","author":"J Burris","year":"2014","unstructured":"Burris J, Weis M. Reduction of erosion risk in adult patients with implanted venous access ports. Clin J Oncol Nurs. 2014;18(4):403\u20135. https:\/\/doi.org\/10.1188\/14.CJON.403-405.","journal-title":"Clin J Oncol Nurs"},{"issue":"8","key":"3817_CR14","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1007\/s00423-022-02656-9","volume":"407","author":"K Thiel","year":"2022","unstructured":"Thiel K. Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports\u2014a complication analysis of more than 1000 TIVAP implantations. Langenbecks Arch Surg. 2022;407(8):3755\u201362. https:\/\/doi.org\/10.1007\/s00423-022-02656-9.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"3817_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11739-008-0125-3","volume":"3","author":"M Verso","year":"2008","unstructured":"Verso M. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med. 2008;3(2):117\u201322. https:\/\/doi.org\/10.1007\/s11739-008-0125-3.","journal-title":"Intern Emerg Med"},{"issue":"2","key":"3817_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0049-3848(97)00054-6","volume":"86","author":"M De Cicco","year":"1997","unstructured":"De Cicco M. CENTRAL VENOUS THROMBOSIS: AN EARLY AND FREQUENT COMPLICATION IN CANCER PATIENTS BEARING LONG-TERM SILASTIC CATHETER. A PROSPECTIVE STUDY. Thromb Res. 1997;86(2):101\u201313. https:\/\/doi.org\/10.1016\/S0049-3848(97)00054-6.","journal-title":"Thromb Res"},{"issue":"1","key":"3817_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1445-5994.1996.tb02904.x","volume":"26","author":"PS Craft","year":"1996","unstructured":"Craft PS, May J, Dorigo A, Hoy C, Plant A. Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications. Aust N Z J Med. 1996;26(1):33\u20139. https:\/\/doi.org\/10.1111\/j.1445-5994.1996.tb02904.x.","journal-title":"Aust N Z J Med"},{"issue":"6","key":"3817_CR18","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/cncr.25573","volume":"117","author":"JP Erinjeri","year":"2011","unstructured":"Erinjeri JP, Fong AJ, Kemeny NE, Brown KT, Getrajdman GI, Solomon SB. Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement. Cancer. 2011;117(6):1296\u2013301. https:\/\/doi.org\/10.1002\/cncr.25573.","journal-title":"Cancer"},{"key":"3817_CR19","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2019.1897","author":"M Okazaki","year":"2019","unstructured":"Okazaki M. Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: a retrospective analysis. Mol Clin Oncol. 2019. https:\/\/doi.org\/10.3892\/mco.2019.1897.","journal-title":"Mol Clin Oncol"},{"issue":"5","key":"3817_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jvir.2009.01.022","volume":"20","author":"WJ Zawacki","year":"2009","unstructured":"Zawacki WJ. Wound dehiscence or failure to heal following venous access port placement in patients receiving bevacizumab therapy. J Vasc Interv Radiol. 2009;20(5):624\u20137. https:\/\/doi.org\/10.1016\/j.jvir.2009.01.022.","journal-title":"J Vasc Interv Radiol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03817-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03817-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03817-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:00:34Z","timestamp":1781625634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-025-03817-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03817-9","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Ba\u015fak\u015fehir \u00c7am ve Sakura City Hospital approved the current study (Decision No: 2024-39, Date: 11.12.2024). Participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}